Academic Journal
Gisbert R: Costs of chronic bronchitis and COPD: a 1-year follow-up study. Chest 2003, 123(3):784–791. doi:10.1186/1478-7547-11-13 Cite this article as: Darnell et al.: Disproportionate utilization of healthcare resources among veterans with COPD: a retro
| العنوان: | Gisbert R: Costs of chronic bronchitis and COPD: a 1-year follow-up study. Chest 2003, 123(3):784–791. doi:10.1186/1478-7547-11-13 Cite this article as: Darnell et al.: Disproportionate utilization of healthcare resources among veterans with COPD: a retro |
|---|---|
| المؤلفون: | Marc Miravitlles, Md Cristina Murio, Md Tina Guerrero, Ramon Gisbert, Phd Dafne, Study Group |
| المساهمون: | The Pennsylvania State University CiteSeerX Archives |
| المصدر: | http://publications.chestnet.org//pdfAccess.ashx?url=%2Fdata%2FJournals%2FCHEST%2F21990%2F784.pdf. |
| المجموعة: | CiteSeerX |
| مصطلحات موضوعية: | Abbreviations, ATS American Thoracic Society, CI confidence interval, ERS European Respiratory Society |
| الوصف: | Objective: This study attempted to determine the total direct costs derived from the management of chronic bronchitis and COPD in an ambulatory setting through a prospective, 1-year, follow-up study. Method: A total of 1,510 patients with chronic bronchitis and COPD were recruited from 268 general practices located throughout Spain. Patients were followed up for 1 year. All direct medical costs incurred by the cohort and related to their respiratory disease were quantified. Costs were calculated for patients with confirmed COPD according to the degree of severity of airflow obstruction. Results: The global mean direct yearly cost of chronic bronchitis and COPD was $1,876. The cost generated by patients with COPD was $1,760, but the cost of severe COPD ($2,911) was almost double that of mild COPD ($1,484). Hospitalization costs represented 43.8 % of costs, drug acquisition costs were 40.8%, and clinic visits and diagnostic tests represented only 15.4 % of costs. Conclusion: This is the first prospective follow-up study on a large cohort of patients with chronic bronchitis and COPD aimed at quantifying direct medical costs under usual clinical practice in the community. Costs of chronic bronchitis and COPD were almost twofold those reported for asthma. Patterns of COPD management in the community differ from those recommended in guidelines. COPD represents a great health-care burden in developed countries, and aging of the population and continuing smoking habits predict that it will continue to do so in the future. (CHEST 2003; 123:784–791) Key words: chronic bronchitis; COPD; cost; pharmacoeconomics; primary care; treatment primary care |
| نوع الوثيقة: | text |
| وصف الملف: | application/pdf |
| اللغة: | English |
| Relation: | http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.457.7366; http://publications.chestnet.org//pdfAccess.ashx?url=%2Fdata%2FJournals%2FCHEST%2F21990%2F784.pdf |
| الاتاحة: | http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.457.7366 http://publications.chestnet.org//pdfAccess.ashx?url=%2Fdata%2FJournals%2FCHEST%2F21990%2F784.pdf |
| Rights: | Metadata may be used without restrictions as long as the oai identifier remains attached to it. |
| رقم الانضمام: | edsbas.449B7D50 |
| قاعدة البيانات: | BASE |
| الوصف غير متاح. |